[{"AccountsPayableCurrent_0_Q2_USD":73995000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":-9000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":-2845000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":4527000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":4527000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-2854000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":0.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-2845000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-9000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":20570000.0,"OtherNoncashIncomeExpense_2_Q2_USD":-3855000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":2659000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-3934000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":0.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":2167000.0,"OtherLiabilitiesCurrent_0_Q2_USD":9887000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":4527000.0,"OtherAssetsNoncurrent_0_Q2_USD":40373000.0,"OperatingIncomeLoss_2_Q2_USD":-554461000.0,"InterestPaidNet_2_Q2_USD":10046000.0,"InvestmentIncomeNet_1_Q2_USD":369000.0,"InvestmentIncomeNet_2_Q2_USD":731000.0,"Liabilities_0_Q2_USD":2004025000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":2749587000.0,"LiabilitiesCurrent_0_Q2_USD":1651516000.0,"LongTermDebtPercentageBearingFixedInterestRate_0_Q2_pure":0.0375,"MarketableSecuritiesCurrent_0_Q2_USD":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":538144000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":128708000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":807497000.0,"NetIncomeLoss_1_Q2_USD":-352317000.0,"NetIncomeLoss_2_Q2_USD":-575036000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"OperatingIncomeLoss_1_Q2_USD":-345829000.0,"PaymentsToAcquireProductiveAssets_2_Q2_USD":28932000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":162351000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":564859000.0,"ProceedsFromIssuanceOfPreferredStockAndPreferenceStock_2_Q2_USD":0.0,"ShortTermLeaseCost_1_Q2_USD":86600000.0,"ShortTermLeaseCost_2_Q2_USD":214200000.0,"StockholdersEquity_0_Q2_USD":745562000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":564859000.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q2_USD":0.0,"TemporaryEquityParOrStatedValuePerShare_0_Q2_USD":0.01,"TemporaryEquitySharesAuthorized_0_Q2_shares":2000000.0,"TemporaryEquitySharesIssued_0_Q2_shares":0.0,"TemporaryEquitySharesOutstanding_0_Q2_shares":0.0,"TreasuryStockShares_0_Q2_shares":424072.0,"TreasuryStockValue_0_Q2_USD":47205000.0,"UnamortizedDebtIssuanceExpense_0_Q2_USD":2254000.0,"UnbilledReceivablesCurrent_0_Q2_USD":21374000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":74118000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":73580000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":865000000.0,"InterestExpenseDebtExcludingAmortization_2_Q2_USD":6094000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":131.66,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":115000000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":159807000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":26903000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":213186000.0,"ReceivablesNetCurrent_0_Q2_USD":49989000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":570685000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":1163356000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q2_USD":46398000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q2_USD":1461000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-2449235000.0,"Revenues_1_Q2_USD":298017000.0,"Revenues_2_Q2_USD":745246000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q2_USD":11400000.0,"SecurityDeposit_0_Q2_USD":1500000.0,"ShareBasedCompensation_2_Q2_USD":106183000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":121000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q2_USD":166.66,"InterestExpenseDebtExcludingAmortization_1_Q2_USD":3047000.0,"InterestExpenseDebt_2_Q2_USD":6806000.0,"InterestExpenseDebt_1_Q2_USD":3403000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":1474001000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommonStockSharesAuthorized_0_Q2_shares":600000000.0,"CommonStockSharesIssued_0_Q2_shares":74672351.0,"CommonStockSharesOutstanding_0_Q2_shares":74248279.0,"CommonStockValue_0_Q2_USD":747000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-347790000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-577890000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":322746000.0,"CostsAndExpenses_1_Q2_USD":643846000.0,"CostsAndExpenses_2_Q2_USD":1299707000.0,"CurrentForeignTaxExpenseBenefit_1_Q2_USD":3500000.0,"CurrentForeignTaxExpenseBenefit_2_Q2_USD":6600000.0,"DebtInstrumentFaceAmount_0_Q2_USD":325000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":2122739000.0,"DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestBeforeAllowanceForCreditLoss_0_Q2_USD":0.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":2074880000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":0.0,"AccruedLiabilitiesCurrent_0_Q2_USD":249178000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q2_USD":4200000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":4170000.0,"AdditionalPaidInCapital_0_Q2_USD":3237085000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":53123000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":106183000.0,"AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_2_Q2_USD":7292000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":53123000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":106183000.0,"AmortizationOfFinancingCosts_1_Q2_USD":356000.0,"AmortizationOfFinancingCosts_2_Q2_USD":712000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":200000.0,"Assets_0_Q2_USD":2749587000.0,"AssetsCurrent_0_Q2_USD":2354992000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":11037000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":73580000.0,"DebtSecuritiesAvailableForSaleExcludingAccruedInterest_0_Q2_USD":0.0,"EarningsPerShareBasic_1_Q2_USD":-4.75,"GeneralAndAdministrativeExpense_1_Q2_USD":73161000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":136351000.0,"Goodwill_0_Q2_USD":134294000.0,"GoodwillForeignCurrencyTranslationGainLoss_2_Q2_USD":-1085000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-348769000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-568471000.0,"IncomeTaxesPaidNet_2_Q2_USD":3017000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":3548000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":6565000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":115212000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":946845000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-193004000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":5281000.0,"InterestExpense_1_Q2_USD":5968000.0,"InterestExpense_2_Q2_USD":10807000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":5281000.0,"DeferredRevenueCurrent_0_Q2_USD":1220073000.0,"FiniteLivedIntangibleAssetsGross_0_Q2_USD":12688000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":437000.0,"EarningsPerShareBasic_2_Q2_USD":-7.82,"EarningsPerShareDiluted_2_Q2_USD":-7.82,"EarningsPerShareDiluted_1_Q2_USD":-4.75,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":-348000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":230000000.0,"FinanceLeaseInterestExpense_1_Q2_USD":1800000.0,"FinanceLeaseInterestExpense_2_Q2_USD":4000000.0,"FinanceLeaseLiabilityCurrent_0_Q2_USD":98383000.0,"FinanceLeaseLiabilityNoncurrent_0_Q2_USD":9193000.0,"FinanceLeasePrincipalPayments_2_Q2_USD":53618000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":7407000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":437000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":219000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":437000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":437000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":437000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":74118000.0,"Ticker":"NVAX","CIK":"1000694","name":"NOVAVAX INC","OfficialName":"Novavax Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4164288206.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]